Matches in Nanopublications for { ?s ?p "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP400325.RABPrbeqSmosJOZfiUpnUoQNpkfvKdx8ZlAPm8czGwlOg130_assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400325.RABPrbeqSmosJOZfiUpnUoQNpkfvKdx8ZlAPm8czGwlOg130_provenance.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_provenance.
- NP665802.RA7QQrfDCAfcoLgYQ7cnUjhPn07Zq6hSdGH1TXaCjH71o130_assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665802.RA7QQrfDCAfcoLgYQ7cnUjhPn07Zq6hSdGH1TXaCjH71o130_provenance.
- NP861785.RAK8tIStAj8Uy6DBgbj1n63_9-d89MixflAXOnwoMkPTA130_assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861785.RAK8tIStAj8Uy6DBgbj1n63_9-d89MixflAXOnwoMkPTA130_provenance.
- NP400330.RAPojSXkJyrAg25QfzcFvcrYI0tvGb8N6ZYj9clWTQKlQ130_assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400330.RAPojSXkJyrAg25QfzcFvcrYI0tvGb8N6ZYj9clWTQKlQ130_provenance.